|
|
|
41
|
4941U
|
ALBUREX 25% INJ (CSL) ALBUMIN (BQ)
|
ALBUMIN
|
ALBUREX
|
50ML VIAL
|
BQ
|
91.06
|
91.0639
|
VIAL
|
40
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
49511
|
FERRUM FOL CHEWABLE 100/350 TAB (VFI/AHI) IRO
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
FERRUM FOL CHEWABLE
|
30'S
|
C
|
33.87
|
1.13
|
TABLET
|
0
|
TAB
|
VFI
|
VIFOR (INTERNATIONAL) INC,
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-29
|
|
|
|
40
|
49513
|
OROFER CHEWABLE 350MCG | 100MG TAB (EMC/COL) FO
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER CHEWABLE
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
49513
|
OROFER CHEWABLE 350MCG|100MG TAB (EMC) F
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER CHEWABLE
|
30'S
|
A
|
6.12
|
0.2039
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
49513
|
OROFER 350MCG|100MG CHEW TAB (EMC) FOLIC ACID|IRON 3 HYDROXY
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
30'S
|
A
|
9.79
|
0.33
|
TAB
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
40
|
49514
|
OROFER 550MCG | 100MG CAP (EMC/COL) FOLIC ACID |
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
40'S
|
A
|
4.08
|
0.10
|
CAPSULE
|
30
|
CAP
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
49514
|
OROFER 550MCG|100MG CAP (EMC) FOLIC ACID
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
40'S
|
A
|
4.62
|
0.1155
|
CAP
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
49514
|
OROFER 550MCG|100MG CAP (EMC) FOLIC ACID|IRON 3 HYDROXY POLY
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
40'S
|
A
|
10.33
|
0.26
|
CAP
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
40
|
49712
|
APO-HYDROXYUREA 500MG CAP (APO/COL)
|
HYDROXYUREA
|
APO-HYDROXYUREA
|
100'S
|
C
|
93.70
|
0.94
|
CAPSULE
|
0
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
49712
|
APO-HYDROXYUREA 500MG CAP (APO)
|
HYDROXYUREA
|
APO-HYDROXYUREA
|
100'S
|
C
|
46.21
|
0.46
|
CAP
|
150
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4971J
|
HYDROXYUREA 500MG CAP (SLS/AHI)
|
HYDROXYUREA
|
HYDROXYUREA
|
100'S
|
A
|
33.30
|
0.33
|
CAPSULE
|
150
|
CAP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4971N
|
HYDROXYUREA 500MG CAP (FSB)
|
HYDROXYUREA
|
HYDROXYUREA
|
100'S
|
A
|
25.14
|
0.2514
|
CAP
|
150
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4971X
|
ZYDROX 500MG CAP (ZUV) HYDROXYUREA
|
HYDROXYUREA
|
ZYDROX
|
100'S
|
A
|
25.12
|
0.2512
|
CAP
|
150
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4971X
|
ZYDROX 500MG CAP (ZUV) HYDROXYUREA
|
HYDROXYUREA
|
ZYDROX
|
100'S
|
A
|
19.38
|
0.19
|
CAP
|
150
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4971Z
|
HYDROFORD 500MG CAP (JLP) HYDROXYUREA
|
HYDROXYUREA
|
HYDROFORD
|
100'S
|
A
|
17.94
|
0.18
|
CAP
|
150
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4981D
|
DACARBAZINE 200MG INJ (CIP/AHI)
|
DACARBAZINE
|
DACARBAZINE
|
200MG VIAL
|
BQ
|
23.02
|
23.02
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4994AU
|
NOLVADEX -D 20MG TAB (AZN/COL) TAMOXIFEN
|
TAMOXIFEN
|
NOLVADEX -D
|
30'S
|
A
|
13.59
|
0.45
|
TABLET
|
60
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4994AU
|
NOLVADEX -D 20MG TAB (AZN) TAMOXIFEN
|
TAMOXIFEN
|
NOLVADEX -D
|
30'S
|
A
|
13.59
|
0.4531
|
TAB
|
60
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4994AU
|
NOLVADEX -D 20MG TAB (AZN) TAMOXIFEN
|
TAMOXIFEN
|
NOLVADEX -D
|
30'S
|
A
|
13.59
|
0.45
|
TAB
|
60
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
50011
|
FERRUM CHEWABLE 100MG TAB (VFI/AHI) IRON 3 HY
|
IRON 3 HYDROXY POLYMALTOSE
|
FERRUM CHEWABLE
|
30'S
|
A
|
37.65
|
1.26
|
TABLET
|
30
|
TAB
|
VFI
|
VIFOR (INTERNATIONAL) INC,
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
